Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
40%(4 trials)

Phase Distribution

Ph phase_3
3
27%
Ph phase_1
1
9%
Ph phase_4
3
27%
Ph phase_2
3
27%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Other(1)

Detailed Status

Completed10
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 33 (30.0%)
Phase 43 (30.0%)

Trials by Status

completed1091%
unknown19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_3

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

NCT00127166
unknownphase_4

Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

NCT04503460
completed

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

NCT00557180
completedphase_1

Generation of Biological Samples Positive to Salmeterol for Anti-Doping Control

NCT04195867
completedphase_3

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

NCT00565266
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00127166Phase 3

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

Completed
NCT04503460Phase 4

Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

Unknown
NCT00557180

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Completed
NCT04195867Phase 1

Generation of Biological Samples Positive to Salmeterol for Anti-Doping Control

Completed
NCT00565266Phase 3

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

Completed
NCT00102882Phase 4

Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate

Completed
NCT01712451Phase 2

Dose-ranging Study

Completed
NCT00975195Phase 4

Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease

Completed
NCT02242227Phase 2

Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT00350207Phase 2

Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

Completed
NCT00269126Phase 3

Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11